Excel spreadsheet of annual numbers of new drugs launched in the UK from 1971 to 2011. Contains data in 6 columns: A: Year. B-D: Data from NIHR HSC, derived from new preparations added to the BNF from 1982-2011. Shows numbers of NCEs, new biologics and totals for each year. E: Data from CMR (1991), published by Tansey et al(1994). Shows numbers of NCEs for each year from 1971-1989. F: Combines data from columns D & E to show numbers of new drugs from 1971-2011. Years 1982-89 show the average of the two values, rounded to the nearest whole number
Analysis of new anticancer drugs licensed in the UK found that 44 new therapies were approved from 2...
Objectives To investigate the trend in the launch price of new drugs for five common health conditio...
SIGLEAvailable from British Library Document Supply Centre- DSC:MFE 1169(CH--1011)(microfiche) / BLD...
Excel spreadsheet of annual numbers of new drugs launched in the UK from 1971 to 2011. Contains data...
Objective: To describe trends in new drugs launched in the UK from 1982 to 2011 and test the hypothe...
Objectives: Innovative new drugs offer potential benefits to patients, healthcare systems, governmen...
New drugs listed in the British National Formulary (BNF) from 2001 to 2012 (inclusive) categorised a...
The United Kingdom (UK) Focal Point on Drugs is based at Public Health England. It is the national p...
<p>Historic data of the numbers of nature-derived approved drugs from previously untapped and previo...
The Statistical bulletin is published yearly by the EMCDDA and provides access to the most recent st...
Number of NCD medicines with available data on consumption and prices, by disease category and count...
Objectives We aimed to compile and normalise England’s national prescribing data for 1998–2016 to fa...
Trends in new use of antimuscarinic drugs for overactive bladder in Denmark, Sweden, and the United ...
Additional file 1: Table S1. Change in the prescription rate of medications bytherapeutic class. Fig...
Overview of mean NCCs and SD of disease groups and medicines: The number of patients, overall mean N...
Analysis of new anticancer drugs licensed in the UK found that 44 new therapies were approved from 2...
Objectives To investigate the trend in the launch price of new drugs for five common health conditio...
SIGLEAvailable from British Library Document Supply Centre- DSC:MFE 1169(CH--1011)(microfiche) / BLD...
Excel spreadsheet of annual numbers of new drugs launched in the UK from 1971 to 2011. Contains data...
Objective: To describe trends in new drugs launched in the UK from 1982 to 2011 and test the hypothe...
Objectives: Innovative new drugs offer potential benefits to patients, healthcare systems, governmen...
New drugs listed in the British National Formulary (BNF) from 2001 to 2012 (inclusive) categorised a...
The United Kingdom (UK) Focal Point on Drugs is based at Public Health England. It is the national p...
<p>Historic data of the numbers of nature-derived approved drugs from previously untapped and previo...
The Statistical bulletin is published yearly by the EMCDDA and provides access to the most recent st...
Number of NCD medicines with available data on consumption and prices, by disease category and count...
Objectives We aimed to compile and normalise England’s national prescribing data for 1998–2016 to fa...
Trends in new use of antimuscarinic drugs for overactive bladder in Denmark, Sweden, and the United ...
Additional file 1: Table S1. Change in the prescription rate of medications bytherapeutic class. Fig...
Overview of mean NCCs and SD of disease groups and medicines: The number of patients, overall mean N...
Analysis of new anticancer drugs licensed in the UK found that 44 new therapies were approved from 2...
Objectives To investigate the trend in the launch price of new drugs for five common health conditio...
SIGLEAvailable from British Library Document Supply Centre- DSC:MFE 1169(CH--1011)(microfiche) / BLD...